| Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 |
|---|---|---|---|---|---|---|---|---|
Sales, net | ||||||||
7,314 | 5,923 | 4,761 | - | - | - | - | - | - |
Product sales, net | ||||||||
- | - | - | 4,769 | - | - | - | - | - |
Cost of sales | ||||||||
4,267 | 4,081 | 3,923 | 4,640 | - | - | - | - | - |
Product sales, net | ||||||||
- | - | - | - | 4,606 | 4,219 | 4,525 | 5,071 | 5,238 |
Cost of product sales | ||||||||
- | - | - | - | 4,439 | 4,415 | 4,375 | 4,367 | 4,081 |
Gross profit | ||||||||
3,047 | 1,842 | 838 | 129 | 167 | -196 | 150 | 703 | 1,157 |
Research and development: | ||||||||
Proprietary research and development | ||||||||
1,429 | 1,351 | 771 | 528 | 615 | - | - | - | - |
Collaboration arrangement, net of reimbursement | ||||||||
45 | 395 | 194 | 0 | 0 | - | - | - | - |
Total research and development | ||||||||
1,474 | 1,746 | 965 | 528 | 615 | 668 | 627 | 780 | 981 |
Research and development reimbursement | ||||||||
- | - | - | - | - | - | - | 50 | 515 |
Sales and marketing | ||||||||
2,679 | 2,660 | 2,310 | 1,353 | 1,488 | 1,234 | 1,296 | 1,215 | 1,232 |
(Gain) on equipment disposal | ||||||||
24 | - | 2 | - | - | - | - | - | - |
General and administrative | ||||||||
4,172 | 4,165 | 3,920 | 3,786 | 2,401 | 2,488 | 2,294 | 2,355 | 2,422 |
Gain on change in estimate of asset retirement obligation | ||||||||
- | - | 48 | 456 | - | - | - | - | - |
Change in estimate of asset retirement obligation | ||||||||
- | - | - | - | 0 | 0 | - | - | - |
Total operating expenses | ||||||||
8,301 | 8,571 | 7,145 | 5,211 | 4,504 | 4,391 | 4,217 | 4,301 | 4,120 |
Operating loss | ||||||||
-5,254 | -6,729 | -6,307 | -5,082 | -4,337 | -4,588 | -4,067 | -3,597 | -2,962 |
Non-operating income: | ||||||||
Interest income, net | ||||||||
108 | 29 | 118 | 218 | 283 | 12 | 0 | 0 | 3 |
Change in fair value of warrant derivative liability | ||||||||
- | - | 27 | 154 | 375 | -1,382 | 210 | 170 | 334 |
Other income | ||||||||
2 | - | - | - | - | - | - | - | - |
Financing and interest expense | ||||||||
- | - | - | 1 | 2 | 0 | 0 | - | - |
Financing and interest expense | ||||||||
- | - | - | - | - | - | - | 61 | 216 |
Non-operating income | ||||||||
110 | 29 | 145 | 371 | 656 | -1,370 | 210 | 109 | 120 |
Net loss | ||||||||
-5,144 | -6,700 | -6,162 | -4,711 | -3,681 | -5,959 | -3,856 | -3,488 | -2,842 |
Preferred stock deemed dividends | ||||||||
- | - | - | - | - | 726 | 0 | - | - |
Preferred stock dividends | ||||||||
11 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 10 |
Net loss applicable to common shareholders | ||||||||
-5,155 | -6,711 | -6,173 | -4,722 | -3,692 | -6,696 | -3,867 | -3,499 | -2,852 |
Basic and diluted loss per share (in dollars per share) | ||||||||
-0.08 | -0.12 | -0.11 | -0.09 | -0.07 | -0.16 | -0.11 | -0.12 | -0.11 |
Weighted average shares used in computing net loss per share: | ||||||||
Basic and diluted (in shares) | ||||||||
67,042 | 55,159 | 55,016 | 55,015 | 54,882 | 42,675 | 34,423 | 28,621 | 25,131 |